Ethyl 5-chloropyrazolo[1,5-a]pyrimidine-2-carboxylate

Catalog No.: 
ACVUCD356
CAS No.: 
1363405-21-3
Molecular Formula: 
C9H8ClN3O2
Molecular Weight: 
225.63
Ethyl 5-chloropyrazolo[1,5-a]pyrimidine-2-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25mg97%$137.00In stockInquiry
50mg97%$225.00In stockInquiry
100mg97%$396.00In stockInquiry
250mg97%$768.00In stockInquiry
500mg97%$1065.00In stockInquiry
1g97%$1622.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 5-chloropyrazolo[1,5-a]pyrimidine-2-carboxylate
IUPAC Nameethyl 5-chloropyrazolo[1,5-a]pyrimidine-2-carboxylate
MDL No.MFCD21607428
Molecular FormulaC9H8ClN3O2
Molecular Weight225.63
SMILESO=C(C1=NN2C=CC(Cl)=NC2=C1)OCC
InChI KeyHVKZDATVDUBOCP-UHFFFAOYSA-N
SynonymETHYL 5-CHLOROPYRAZOLO[1,5-A]PYRIMIDINE-2-CARBOXYLATE;Pyrazolo[1,5-a]pyrimidine-2-carboxylic acid, 5-chloro-, ethyl ester
CAS No.1363405-21-3
PubChem CID71627143

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACVUCD356 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAXHB946 route compound structure diagram
    ACAXHB9461232224-62-2In Stock
  2. Then
  3. ACVUCD356 route product structure diagram
    ACVUCD3561363405-21-3In Stock
Inquiry

2. ACVUCD356 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVUCD356 route product structure diagram
    ACVUCD3561363405-21-3In Stock
Inquiry

3. ACVUCD356 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVUCD356 route product structure diagram
    ACVUCD3561363405-21-3In Stock
Inquiry

Comments (0)